These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 32880951)

  • 21. Mutations of KIF5C cause a neurodevelopmental disorder of infantile-onset epilepsy, absent language, and distinctive malformations of cortical development.
    Michels S; Foss K; Park K; Golden-Grant K; Saneto R; Lopez J; Mirzaa GM
    Am J Med Genet A; 2017 Dec; 173(12):3127-3131. PubMed ID: 29048727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ion Channels Involvement in Neurodevelopmental Disorders.
    D'Adamo MC; Liantonio A; Conte E; Pessia M; Imbrici P
    Neuroscience; 2020 Aug; 440():337-359. PubMed ID: 32473276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rodent genetic models of neurodevelopmental disorders and epilepsy.
    Gonzalez-Sulser A
    Eur J Paediatr Neurol; 2020 Jan; 24():66-69. PubMed ID: 31870697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WDR45B-related intellectual disability, spastic quadriplegia, epilepsy, and cerebral hypoplasia: A consistent neurodevelopmental syndrome.
    Suleiman J; Allingham-Hawkins D; Hashem M; Shamseldin HE; Alkuraya FS; El-Hattab AW
    Clin Genet; 2018 Feb; 93(2):360-364. PubMed ID: 28503735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Protocadherin 19 (PCDH19) in Neurodevelopment and in the Pathophysiology of Early Infantile Epileptic Encephalopathy-9 (EIEE9).
    Gerosa L; Francolini M; Bassani S; Passafaro M
    Dev Neurobiol; 2019 Jan; 79(1):75-84. PubMed ID: 30431232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Transfer Therapy for Neurodevelopmental Disorders.
    Ozlu C; Bailey RM; Sinnett S; Goodspeed KD
    Dev Neurosci; 2021; 43(3-4):230-240. PubMed ID: 33882495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future.
    van Karnebeek CD; Bowden K; Berry-Kravis E
    Pediatr Neurol; 2016 Dec; 65():1-13. PubMed ID: 27697313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerating therapeutic development and clinical trial readiness for STXBP1 and SYNGAP1 disorders.
    Marotta N; Boland MJ; Prosser BL
    Curr Probl Pediatr Adolesc Health Care; 2024 Aug; 54(8):101576. PubMed ID: 38472035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders.
    McLachlan F; Sires AM; Abbott CM
    Hum Mutat; 2019 Feb; 40(2):131-141. PubMed ID: 30370994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic studies in intellectual disability and related disorders.
    Vissers LE; Gilissen C; Veltman JA
    Nat Rev Genet; 2016 Jan; 17(1):9-18. PubMed ID: 26503795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soma-to-germline transformation in chromatin-linked neurodevelopmental disorders?
    Bonefas KM; Iwase S
    FEBS J; 2022 Apr; 289(8):2301-2317. PubMed ID: 34514717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurodevelopmental disorder associated with de novo SCN3A pathogenic variants: two new cases and review of the literature.
    Inuzuka LM; Macedo-Souza LI; Della-Ripa B; Cabral KSS; Monteiro F; Kitajima JP; de Souza Godoy LF; de Souza Delgado D; Kok F; Garzon E
    Brain Dev; 2020 Feb; 42(2):211-216. PubMed ID: 31677917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating the effect size of the 15Q11.2 BP1-BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice.
    Jønch AE; Douard E; Moreau C; Van Dijck A; Passeggeri M; Kooy F; Puechberty J; Campbell C; Sanlaville D; Lefroy H; Richetin S; Pain A; Geneviève D; Kini U; Le Caignec C; Lespinasse J; Skytte AB; Isidor B; Zweier C; Caberg JH; Delrue MA; Møller RS; Bojesen A; Hjalgrim H; Brasch-Andersen C; Lemyre E; Ousager LB; Jacquemont S;
    J Med Genet; 2019 Oct; 56(10):701-710. PubMed ID: 31451536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of Ion Channels by MicroRNAs and the Implication for Epilepsy.
    Gross C; Tiwari D
    Curr Neurol Neurosci Rep; 2018 Jul; 18(9):60. PubMed ID: 30046905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bi-allelic TMEM94 Truncating Variants Are Associated with Neurodevelopmental Delay, Congenital Heart Defects, and Distinct Facial Dysmorphism.
    Stephen J; Maddirevula S; Nampoothiri S; Burke JD; Herzog M; Shukla A; Steindl K; Eskin A; Patil SJ; Joset P; Lee H; Garrett LJ; Yokoyama T; Balanda N; Bodine SP; Tolman NJ; Zerfas PM; Zheng A; Ramantani G; Girisha KM; Rivas C; Suresh PV; Elkahloun A; Alsaif HS; Wakil SM; Mahmoud L; Ali R; Prochazkova M; ; Kulkarni AB; Ben-Omran T; Colak D; Morris HD; Rauch A; Martinez-Agosto JA; Nelson SF; Alkuraya FS; Gahl WA; Malicdan MCV
    Am J Hum Genet; 2018 Dec; 103(6):948-967. PubMed ID: 30526868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UBR7 functions with UBR5 in the Notch signaling pathway and is involved in a neurodevelopmental syndrome with epilepsy, ptosis, and hypothyroidism.
    Li C; Beauregard-Lacroix E; Kondratev C; Rousseau J; Heo AJ; Neas K; Graham BH; Rosenfeld JA; Bacino CA; Wagner M; Wenzel M; Al Mutairi F; Al Deiab H; Gleeson JG; Stanley V; Zaki MS; Kwon YT; Leroux MR; Campeau PM
    Am J Hum Genet; 2021 Jan; 108(1):134-147. PubMed ID: 33340455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurodevelopmental synaptopathies: Insights from behaviour in rodent models of synapse gene mutations.
    Luo J; Norris RH; Gordon SL; Nithianantharajah J
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt B):424-439. PubMed ID: 29217145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurodevelopmental spectrum of synaptic vesicle cycling disorders.
    John A; Ng-Cordell E; Hanna N; Brkic D; Baker K
    J Neurochem; 2021 Apr; 157(2):208-228. PubMed ID: 32738165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial Dysfunction: A Common Denominator in Neurodevelopmental Disorders?
    Ortiz-González XR
    Dev Neurosci; 2021; 43(3-4):222-229. PubMed ID: 34350863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delineating SPTAN1 associated phenotypes: from isolated epilepsy to encephalopathy with progressive brain atrophy.
    Syrbe S; Harms FL; Parrini E; Montomoli M; Mütze U; Helbig KL; Polster T; Albrecht B; Bernbeck U; van Binsbergen E; Biskup S; Burglen L; Denecke J; Heron B; Heyne HO; Hoffmann GF; Hornemann F; Matsushige T; Matsuura R; Kato M; Korenke GC; Kuechler A; Lämmer C; Merkenschlager A; Mignot C; Ruf S; Nakashima M; Saitsu H; Stamberger H; Pisano T; Tohyama J; Weckhuysen S; Werckx W; Wickert J; Mari F; Verbeek NE; Møller RS; Koeleman B; Matsumoto N; Dobyns WB; Battaglia D; Lemke JR; Kutsche K; Guerrini R
    Brain; 2017 Sep; 140(9):2322-2336. PubMed ID: 29050398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.